Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Precise coordination of the S and M phases of the eukaryotic cell cycle is critical not only for normal cell division, but also for effective growth arrest under conditions of stress. When damaged, a cell must communicate signals to both the mitotic and DNA synthesis machineries so that a mitotic block is not followed by an extra S phase, or vice versa. The biochemical mechanisms regulating this coordination, termed checkpoints, have been identified in lower eukaryotes, but are largely unknown in mammalian cells. Here we show that p21 WAF1/CIP1, the prototype inhibitor of cyclin-dependent kinases (CDKs), is required for this coordination in human cells. In the absence of p21, DNA-damaged cells arrest in a G2-like state, but then undergo additional S phases without intervening normal mitoses. They thereby acquire grossly deformed, polyploid nuclei and subsequently die through apoptosis. Perhaps not by coincidence, the DNA-damaging agents that can cause S/M uncoupling are used in the clinic to kill cancer cells preferentially.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, after transiently arresting in G2, HCT-116 cells in which p21 was knocked out eventually underwent aberrant mitoses, leading to polyploidy or cell death.53,55”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [53]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., & Jacks, T. (1995) · Genes & Development · doi:10.1101/gad.9.8.935 · Cited by 1,119
Self-citationGorczyca, W., GONG, J., & Darżynkiewicz, Z. (1993) · PubMed · Cited by 982
Creative blocks: cell-cycle checkpoints and feedback controls
Murray, A. W. (1992) · Nature · doi:10.1038/359599a0 · Cited by 663
A p53-Dependent Mouse Spindle Checkpoint
Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., & Reid, B. J. (1995) · Science · doi:10.1126/science.7871434 · Cited by 660
Ordering S phase and M phase in the cell cycle
Nurse, P. (1994) · Cell · doi:10.1016/0092-8674(94)90539-8 · Cited by 589
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
El‐Deiry, W. S., Tokino, T., Waldman, T. A., Oliner, J., Velculescu, V. E., Burrell, M., HILL, D. E., Healy, E., Rees, J. L., & Hamilton, S. R. (1995) · PubMed · Cited by 582
Self-citation
Research works printed but not linked: 8
- Waldman, T., Kinzler, K. W. & Vogelstein, B. Cancer Res. 55, 5187–5190 (1995).
- Gorczyca, W., Gong, J. & Darzynkiewicz, Z. Cancer Res. 53, 1945–1951 (1993).
- Gao, X. et al. Oncogene 11, 1395–1398 (1995).
- El-Deiry, W. A. et al. Cancer Res. 55, 2910–2919 (1995).
- Kung, A. L., Zetterberg, A., Sherwood, S. W. & Schimke, R. T. Cancer Res. 50, 7307–7317 (1990).
- Carder, P. et al. Oncogene 8, 1397–1401 (1993).
- Harvey, M. et al. Oncogene 8, 2457–2467 (1993).
- Morrow, C. S. & Cowan, K. H. in Cancer Medicine (eds Holland, J. F. et al.), 618–631 (Lea & Febiger, Philadelphia, 1993).
Cited by
Items 501–600 of 727
Koga, F., Kitahara, S., Arai, K., Honda, M., Sumi, S., & Yoshida, K. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00961.x · Cited by 22
Hwang, P. H., Kim, S. Y., Lee, J. C., Kim, S. J., Yi, H. K., & Lee, D. (2005) · Experimental & Molecular Medicine · doi:10.1038/emm.2005.49 · Cited by 22
Hu, M., Wang, J., Chen, P., & Reilly, R. M. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060053r · Cited by 22
Vrana, J. A., Kramer, L. B., Saunders, A. M., Zhang, X.-F., Dent, P., Povirk, L. F., & Grant, S. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00077-5 · Cited by 22
High-risk metastatic urothelial cancer: chances for cure?
Calabrò, F., & Sternberg, C. N. (2002) · Current Opinion in Urology · doi:10.1097/00042307-200209000-00013 · Cited by 22
Cell Cycle Checkpoint Genes and Cancer
Funk, J. O. (2006) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0006046 · Cited by 22
Liu, X., Xia, Y., Li, M., Wang, H., He, Y., Zheng, M., Yang, H., & Huang, W. (2006) · Cell Biology International · doi:10.1016/j.cellbi.2005.11.010 · Cited by 21
Mohapatra, D. K., Reddy, D. S., Ramaiah, M. J., Ghosh, S., Pothula, V., Lunavath, S., Thomas, S., Valli, S. N. C. V. L. P., Bhadra, M. P., & Yadav, J. S. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.01.030 · Cited by 22
p21 and p53 Immunostaining and Survival following Systemic Chemotherapy for Urothelial Cancer
Jankevičius, F., Goebell, P. J., Kushima, M., Schulz, W. A., Ackermann, R., & Schmitz‐Dräger, B. J. (2002) · Urologia Internationalis · doi:10.1159/000063949 · Cited by 25
Therapeutic targeting of the p53 tumor suppressor gene
Beaudry, G. A. (1996) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(96)80069-3 · Cited by 21
Maaser, K., Sutter, A. P., Krahn, A., Höpfner, M., Grabowski, P., & Scherübl, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.127 · Cited by 21
Pindzola, J. A., Palazzo, J., Kovatich, A. J., Tuma, B., & Nobel, M. (1998) · Pathology - Research and Practice · doi:10.1016/s0344-0338(98)80127-1 · Cited by 21
Relationship between p21/waf-1/cip-1 and apoptosis in cervical cancer during radiation therapy
Niibe, Y., Nakano, T., Ohno, T., Tsujii, H., & Oka, K. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00026-7 · Cited by 23
Levandowski, C. B., Jones, T., Gruca, M. A., Ramamoorthy, S., Dowell, R. D., & Taatjes, D. J. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3001364 · Cited by 19
Ahn, J., Ko, M., Lee, C., Kim, J., Yoon, H.-S., & Seong, R. H. (2010) · Oncogene · doi:10.1038/onc.2010.424 · Cited by 20
Datta, N. S., Williams, J. L., & Long, M. W. (1998) · PubMed · Cited by 25
Role of P53 Mutations in the Radiosensitivity Status of Tumor Cells
Chiarugi, V. P., Magnelli, L., & Cinelli, M. (1998) · Tumori Journal · doi:10.1177/030089169808400501 · Cited by 20
Vitiello, P. F., Staversky, R. J., Gehen, S. C., Johnston, C. J., Finkelstein, J. N., Wright, T. W., & O’Reilly, M. A. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051162 · Cited by 19
Ma, W., Hommel, C., Brenneisen, P., Peters, T., Smit, N., Sedivy, J., Scharffetter‐Kochanek, K., & Wlaschek, M. (2003) · Experimental Dermatology · doi:10.1034/j.1600-0625.2003.00024.x · Cited by 19
Characterisation of genotoxic properties of 2′,2′-difluorodeoxycytidine
Auer, H., Oehler, R., Lindner, R., Kowalski, H., Sliutz, G., Orel, L., Kučera, E., Simon, M. M., & Glössl, J. (1997) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(97)00102-2 · Cited by 19
Giant cell formation: the way to cell death or cell survival?
Horbay, R., & Stoika, R. S. (2011) · Open Life Sciences · doi:10.2478/s11535-011-0058-0 · Cited by 20
Zopf, S., Neureiter, D., Bouralexis, S., Abt, T., Glaser, K. B., Okamoto, K., Ganslmayer, M., Hahn, E. G., Herold, C., & Ocker, M. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.6.1391 · Cited by 25
EAPP: Gatekeeper at the crossroad of apoptosis and p21-mediated cell-cycle arrest
Andorfer, P., & Rotheneder, H. (2011) · Oncogene · doi:10.1038/onc.2010.639 · Cited by 19
The Biology of p21Waf1/Cip1 - Review Paper
Blundell, R. A. (2006) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2006.33.40 · Cited by 18
Potential Role for Targeted Therapy in Muscle-Invasive Bladder Cancer
Mitra, A. P., & Lerner, S. P. (2015) · Urologic Clinics of North America · doi:10.1016/j.ucl.2015.01.003 · Cited by 17
Difilippantonio, M. J., Ghadimi, Β. M., Howard, T. A., Camps, J., Nguyen, Q. T., Ferris, D. K., Sackett, D. L., & Ried, T. (2009) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20532 · Cited by 17
Cleistanthin B causes G1 arrest and induces apoptosis in mammalian cells
Kumar, C. P. P., Pande, G., & Shanmugam, G. (1998) · APOPTOSIS · doi:10.1023/a:1009658518998 · Cited by 17
Therrien, J., Loignon, M., Drouin, R., & Drobetsky, E. A. (2001) · PubMed · Cited by 17
A CRITICAL ANALYSIS OF THE USE OF p53 AS A MARKER FOR MANAGEMENT OF BLADDER CANCER
Olumi, A. F. (2000) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70236-6 · Cited by 17
Cell cycle attenuation by p120E4F is accompanied by increased mitotic dysfunction.
Rooney, R. J. (2001) · PubMed · Cited by 17
Bunz, F. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00013 · Cited by 21
Lee, J. Y., Kim, H. S., Kim, J. Y., & Sohn, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.160 · Cited by 20
Banerjee, C., McCabe, L. R., Choi, J.-Y., Hiebert, S. W., Stein, J. L., Stein, G. S., & Lian, J. B. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970701)66:1<1::aid-jcb1>3.0.co;2-v · Cited by 438
Kavurma, M. M., & Khachigian, L. M. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20238 · Cited by 16
Vorburger, S. A., Hetrakul, N., Xia, W., Wilson-Heiner, M., Mirza, N. Q., Pollock, R. E., Feig, B. W., Swisher, S. G., & Hunt, K. K. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0036 · Cited by 16
Cambier, N., Zhang, Y., Vairo, G., Kosmopoulos, K., Metcalf, D., Nicola, N. A., & Elefanty, A. G. (1999) · Oncogene · doi:10.1038/sj.onc.1202302 · Cited by 16
Radiochemotherapy with paclitaxel: Synchronization effects and the role of p53
Wenz, F. K., Greiner, S., Germa, F., Mayer, K. T., Latz, D., & Weber, K. J. (1999) · Strahlentherapie und Onkologie · doi:10.1007/bf03215919 · Cited by 16
Kim, J., Kim, C., Stratford, I. J., Patterson, A. V., & Hendry, J. H. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.040 · Cited by 16
Protein expression pattern in response to ionizing radiation in MCF-7 human breast cancer cells
Jung, S., Lee, S., LEE, J., LI, C., Ohk, J., JEONG, H.-K., Lee, S., Kim, S., Choi, Y., Kim, S., et al. (2011) · Oncology Letters · doi:10.3892/ol.2011.444 · Cited by 17
Genotypic characteristics of resistant tumors to pre-operative ionizing radiation in rectal cancer
Ramzan, Z., Nassri, A. B., & Huerta, S. (2014) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v6.i7.194 · Cited by 15
Sahyon, H. A. E., El‐Shafai, N. M., Elnajjar, N., Althobaiti, F., Aldhahrani, A., Alharbi, N. S., Shoair, A. F., & El‐Mehasseb, I. M. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123633 · Cited by 15
Gene expression profiling in MOLT-4 cells during gamma-radiation-induced apoptosis
Lindgren, T., Stigbrand, T. I., Riklund, K., Johansson, L. F., & Eriksson, D. (2012) · Tumor Biology · doi:10.1007/s13277-012-0329-z · Cited by 18
Apoptosis of Human Tumor Cells by Chemotherapeutic Anthracyclines is Enhanced by Bax Overexpression
Lu, Y., & Yagi, T. (1999) · Journal of Radiation Research · doi:10.1269/jrr.40.263 · Cited by 19
Cell-cycle Alterations in Post-mitotic Cells and Cell Death by Mitotic Catastrophe
Lombardi, D., & Lasagni, L. (2016) · InTech eBooks · doi:10.5772/61783 · Cited by 17
Prabaharan, C. B., Yang, A. B., Chidambaram, D., Rajamanickam, K., Napper, S., & Sakharkar, M. K. (2019) · Investigational New Drugs · doi:10.1007/s10637-019-00837-w · Cited by 17
Wagner, S., & Roemer, K. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.12.017 · Cited by 17
Atkin, N. B. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00102-8 · Cited by 15
Chromosome division figures reveal genomic instability in tumorigenesis of human colon mucosa
Steinbeck, R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.171 · Cited by 15
Bouchal, J., Kolář, Z., Mad’arová, J., Hlobílková, A., & Angerer, E. V. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00927-3 · Cited by 15
New insights into the kinetic resistance to anticancer agents
Chauffert, B., Dimanche‐Boitrel, M., Garrido, C., Ivarsson, M., Martin, M. S., Martin, F., & Solary, É. (1998) · Cytotechnology · doi:10.1023/a:1008025124242 · Cited by 14
Mori, T., Nakagawa, A., KOBAYASHI, N., HASHIMOTO, M. W., Wakabayashi, K., Shimoi, K., & Kinae, N. (1998) · Journal of Radiation Research · doi:10.1269/jrr.39.21 · Cited by 15
State-of-the-art management of metastatic disease at initial presentation or recurrence
Calabrò, F., & Sternberg, C. N. (2006) · World Journal of Urology · doi:10.1007/s00345-006-0115-x · Cited by 14
Dual and opposing roles of ERK in regulating G1 and S-G2/M delays in A549 cells caused by hyperoxia
Ko, J., Wang, Y.-T., & Yang, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.033 · Cited by 14
Bradley, M. W., Aiello, K. A., Ponnapalli, S. P., Hanson, H. A., & Alter, O. (2019) · APL Bioengineering · doi:10.1063/1.5099268 · Cited by 12
Cif type III effector protein: A smart hijacker of the host cell cycle
Samba‐Louaka, A., Taieb, F. E., Nougayrède, J., & Oswald, É. (2009) · Future Microbiology · doi:10.2217/fmb.09.60 · Cited by 12
Zhu, J. Y., Xu, Y., Gu, W., Peng, J., Cai, G., Cai, G., Sun, W., Shen, W., Cai, S., & Zhang, Z. (2010) · Radiation Oncology · doi:10.1186/1748-717x-5-118 · Cited by 14
Gekonge, B., Raymond, A., Yin, X., Kostman, J. R., Mounzer, K., Collman, R. G., Showe, L. C., & Montaner, L. J. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1111552 · Cited by 13
Hygrolidin induces p21 expression and abrogates cell cycle progression at G1 and S phases
Kawada, M., Usami, I., Ohba, S., Someno, T., Kim, J. W., Hayakawa, Y., Nose, K., & Ishizuka, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02416-6 · Cited by 13
Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse
Zou, S.-M., Erbacher, P., Remy, J.-S., & Behr, J.-P. (2000) · The Journal of Gene Medicine · doi:10.1002/(sici)1521-2254(200003/04)2:2<128::aid-jgm95>3.0.co;2-w · Cited by 317
Dubitzky, W., Olaf Wolkenhauer, A., Cho, K., & Yokota, H. (2013) · Springer eBooks · doi:10.1007/978-1-4419-9863-7_100145 · Cited by 14
Present and Future Prospect of Small Molecule & Related Targeted Therapy Against Human Cancer.
Pathak, A., Tanwar, S., Kumar, V., & Banarjee, B. D. (2018) · PubMed · Cited by 19
Homeobox protein VentX induces p53-independent apoptosis in cancer cells
Gao, H., Wu, B., Le, Y., & Zhu, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.9238 · Cited by 13
Low-dose radiation-induced apoptosis in human leukemia K562 cells through mitochondrial pathways
XIN, Y., Zhang, H., Tang, T., Liu, G., WANG, J.-S., Jiang, G., & Zhang, L. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2381 · Cited by 12
Oxidative Stress and Changed Gene Expression Profiles in Fiber-/Particle-Induced Carcinogenesis
Bhattacharya, K., Alink, G. M., & Dopp, E. (2007) · International Journal of Human Genetics · doi:10.1080/09723757.2007.11885981 · Cited by 13
Akimoto, T., Seong, J., Hunter, N. R., Buchmiller, L., Mason, K. A., & Milas, L. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00022-x · Cited by 12
Yoneda, K., Yamamoto, T., Ueta, E., & Osaki, T. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00187-6 · Cited by 12
PROGNOSTIC MARKERS IN BLADDER CANCER
Stein, J. P., Grossfeld, G. D., Ginsberg, D. A., Esrig, D., Freeman, J. A., FIGUEROA, A. J., Skinner, D. G., & Côté, R. J. (1998) · The Journal of Urology · doi:10.1097/00005392-199809010-00003 · Cited by 12
Zhou, Y., Li, G., Ji, Y., Liu, C., Zhu, J., & Lu, Y. (2012) · Journal of Biomedical Science · doi:10.1186/1423-0127-19-15 · Cited by 11
Krishnan, R., Murugiah, M., Lakshmi, N. P., & Mahalingam, S. (2020) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-04-0267 · Cited by 10
Rectal Cancer and Importance of Chemoradiation in the Treatment
Huerta, S. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6448-9_12 · Cited by 11
Zhou, J., Ljungdahl, S., Röhme, D., Levan, G., Shoshan, M. C., & Linder, S. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199709)20:1<38::aid-gcc6>3.0.co;2-a · Cited by 6
Story, M. D., Mirković, N., Hunter, N. R., & Meyn, R. E. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050991 · Cited by 11
Detection of p21WAF1/Cip1 in brain metastases
Ruan, S., Fuller, G. N., Levin, V. A., Bruner, J. M., & Zhang, W. (1998) · Journal of Neuro-Oncology · doi:10.1023/a:1005972808311 · Cited by 11
The role of p53/p21/p16 in DNA damage signaling and DNA repair
Kulaberoglu, Y., Hergovich, A., & Gómez, V. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85679-9.00015-5 · Cited by 18
Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer
Hany, D., Zoetemelk, M., Bhattacharya, K., Nowak-Sliwinska, P. M., & Picard, D. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04730-x · Cited by 9
Davies, C. H., Hogarth, L., MacKenzie, K. L., Hall, A. G., & Lock, R. B. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1100774 · Cited by 11
14-3-3σ and p21 synergize to determine DNA damage response following Chk2 inhibition
Meng, S., Arbit, T., Veeriah, S., Mellinghoff, I. K., Fang, F., Vivanco, I., Rohle, D., & Chan, T. A.-T. (2009) · Cell Cycle · doi:10.4161/cc.8.14.8998 · Cited by 11
Steinbeck, R. G. (1997) · Oral Oncology · doi:10.1016/s0964-1955(96)00068-1 · Cited by 10
MacLaren, A., Clark, W. A., Black, E. J., Gregory, D. J., Fujii, H., & Gillespie, D. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206329 · Cited by 10
Decker, R. H., Levin, J., Kramer, L. B., Dai, Y., & Grant, S. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00149-7 · Cited by 10
Role of p53 in the responses of human urothelial cells to genotoxic damage
Diggle, C. P., Pitt, E., Harnden, P., Trejdosiewicz, L. K., & Southgate, J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1331 · Cited by 10
Nishida, K., Seto, M., & Ishida, R. (2001) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2001.tb01082.x · Cited by 10
Lack of Uncoupling of S Phase and Mitosis after Irradiation in p53 - Human Lymphoblast Cell Lines
Wenz, F. K., Yu, Y., Nagasawa, H., Imrich, A., Keng, P., & Little, J. B. (1997) · Radiation Research · doi:10.2307/3579569 · Cited by 10
The Cell Cycle and Neuronal Cell Death
Freeman, R. S. (1999) · Humana Press eBooks · doi:10.1007/978-1-4612-1602-5_6 · Cited by 13
Ghosh, D., Saha, C., Hossain, M., Dey, S. K., & Kumar, G. S. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2012.698190 · Cited by 9
Zeng, Q., Huang, Y., Zeng, L., Huang, Y., Cai, D., & Zhang, H. (2012) · Cancer Genetics · doi:10.1016/j.cancergen.2012.06.002 · Cited by 9
Yun, U.-J., Park, H.-D., & Shin, D. Y. (2006) · Cancer Research and Treatment · doi:10.4143/crt.2006.38.4.224 · Cited by 9
A mutation in protein phosphatase type 2A as a cause of melanoma progression.
Ito, A., Yi, K., & Watabe, K. (2003) · PubMed · doi:10.14670/hh-18.1313 · Cited by 10
Gao, X., Zhang, G., Shan, S., Shang, Y., Chi, L., Li, H., Cao, Y., Zhu, X., Zhang, M., & Yang, J. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146952 · Cited by 9
Huang, J., & Fisher, R. A. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)86005-5 · Cited by 11
Exploiting Drug-Induced Senescence in Transgenic Mouse Models
Kılıç, M., & Schmitt, C. A. (2008) · CRC Press eBooks · doi:10.3109/9781420020502-17 · Cited by 9
The temporal and spatial distribution of p21WAF expression in skin appendages
Wu, Y.-Y., Takata, M., Rehman, I., & Rees, J. L. (2000) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2000.03414.x · Cited by 9
Uncoupling of S-Phase and Mitosis by Recombinant Cytotoxic Necrotizing Factor 2 (CNF2)
Denko, N. C., Langland, R., Barton, M. C., & Lieberman, M. A. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3595 · Cited by 9
Mujoo, K., Watanabe, M., Khokhar, A. R., & Siddik, Z. H. (2004) · The Prostate · doi:10.1002/pros.20114 · Cited by 10
Satou, M., Aizawa, S., Hayakari, M., Ookawa, K., & Tsuchida, S. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01434.x · Cited by 9
Rasmussen, L. J., Rasmussen, M., Lützen, A., Bisgaard, H. C., & Singh, K. K. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4865 · Cited by 9
The DNA content of chromosome division figures and interphase nuclei classifies ulcerative colitis
Steinbeck, R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00371-7 · Cited by 9
Clinical and molecular prognostic factors in sphincter-preserving surgery for rectal cancer
Jessup, J. M., Loda, M. F., & Bleday, R. (1998) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(98)80038-6 · Cited by 9
Mitotic Catastrophe in Cancer Therapy
Broude, E. V., Lončarek, J., Wada, I., Cole, K., Hanko, C., & Swift, M. E. (2008) · CRC Press eBooks · doi:10.3109/9781420020502-19 · Cited by 8
Larsson, C., & Ng, C. E. (2003) · Radiation Research · doi:10.1667/3031 · Cited by 8
Metadata
- Authors
- Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1996-06
- Volume
- 381
- Issue
- 6584
- Pages
- 713-716
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2008117987
- Cited by
- 728
- References
- 28
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 2 · 2023: 10 · 2022: 1 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 12 · 2017: 5 · 2016: 11 · 2015: 5 · 2014: 8 · 2013: 10 · 2012: 18
- FWCI
- 32.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p21, cell cycle checkpoints, cyclin-dependent kinases, DNA damage response, polyploidy, apoptosis, anticancer agents, cell cycle coordination
- MeSH terms
- Antineoplastic Agents, Camptothecin, DNA Damage, Doxorubicin, Enzyme Inhibitors, Etoposide, Fluorescent Dyes, Gamma Rays, Bisbenzimidazole, Humans, Mitosis, Tumor Cells, Cultured, S Phase, Cyclins, Apoptosis, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.